Quantitative analysis for Freenome Inc. Common stock (FRNM) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 29 signals analyzed (25 differentiated alt-data).
FRNM stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-06 | $11.47 | $11.29 | $11.29 |
| 2026-05-18 | $11.24 | $11.00 | $11.08 |
| 2026-05-29 | $11.43 | $11.14 | $11.14 |
| 2026-06-10 | $11.34 | $11.12 | $11.24 |
| 2026-06-23 | $11.00 | $10.88 | $10.91 |
| 2026-07-06 | $10.95 | $10.81 | $10.83 |
| 2026-07-16 | $12.24 | $11.82 | $12.00 |
| 2026-07-28 | $11.76 | $10.37 | $10.77 |
| 2026-08-07 | $11.29 | $10.90 | $11.15 |
| 2026-08-20 | $13.90 | $13.41 | $13.51 |
| 2026-09-01 | $15.48 | $14.67 | $15.25 |
| 2026-09-14 | $15.00 | $14.25 | $14.96 |
How Freenome Inc. Common stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Freenome Inc. Common stock (FRNM) scores Unrated (50.0), with no measured dimension below 41. Its highest are , across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| earnings quality | 57 |
| technicals | 50 |
| competitive moat | 41 |
StoQuant analyzes 29 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Freenome Inc. Common stock (FRNM): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/FRNM"><img src="https://stoquant.com/badge/FRNM.svg" alt="Freenome Inc. Common stock (FRNM) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.